CLASS II Drug recall · Reported 30 Apr 2025 · FDA Enforcement Report

DoloEar Earache Drops, Homeopathic fl recalled by Pharmadel

Pharmadel is recalling DoloEar Earache Drops, Homeopathic fl, distributed in Delaware. The recall was initiated on 15 Apr 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot, expiry: DEE-01, EXP: OCT 26; DEE-02 EXP: FEB 27
Quantity recalled27,648 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0380-2025
FDA event ID
96639
Recalling firm
Pharmadel, Historic New Castle, DE
Classification
Class II
Status
Terminated
Recall initiated
15 Apr 2025
FDA classified
21 Apr 2025
Reported
30 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

15 Apr 2025Recall initiated by company
21 Apr 2025Classified by FDA+6 days
30 Apr 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP deviations

Product as listed by the FDA

DoloEar Earache Drops, Homeopathic, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-401-15

Where it was distributed

DE

Delaware

Questions about this recall

Is DoloEar Earache Drops, Homeopathic fl recalled?

Yes. Pharmadel recalled DoloEar Earache Drops, Homeopathic fl on 15 Apr 2025. The recall is Class II and its status is Terminated. Recall number D-0380-2025.

Why was it recalled?

cGMP deviations

Which lots are affected?

Lot, expiry: DEE-01, EXP: OCT 26; DEE-02 EXP: FEB 27

Where was it sold?

DE

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pharmadel

All 6

Other Doloear earache recalls

All 2